| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Albers Jeffrey W. is a Director at Spyre Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $2.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | KYMR Kymera Therapeutics, Inc. | Director | Sale+OE | 5,000 | $89.76 | $448,823.09 | -68.9% | -9.8% | - | |
| Oct 13, 2025 | KYMR Kymera Therapeutics, Inc. | Director | Sale+OE | 5,000 | $59.19 | $295,949.00 | -100% | +22.0% | - | |
| Jun 3, 2025 | KYMR Kymera Therapeutics, Inc. | Director | Sale+OE | 6,349 | $49.00 | $311,101.00 | -100% | -6.6% | - | |
| Nov 6, 2024 | SYRE Spyre Therapeutics, Inc. | Director | Sell | 6,700 | $36.76 | $246,312.77 | -19.7% | -36.8% | -40.3% | |
| Oct 25, 2024 | SYRE Spyre Therapeutics, Inc. | Director | Sell | 300 | $36.43 | $10,929.00 | -0.9% | -37.3% | -32.9% | |
| Aug 26, 2024 | KYMR Kymera Therapeutics, Inc. | Director | Sale+OE | 5,000 | $49.10 | $245,508.50 | -100% | -5.5% | -11.8% | |
| Feb 21, 2024 | KYMR Kymera Therapeutics, Inc. | Director | Sale+OE | 5,000 | $39.05 | $195,257.67 | -100% | -8.7% | -3.2% | |
| Jan 23, 2024 | KYMR Kymera Therapeutics, Inc. | Director | Sale+OE | 10,000 | $30.05 | $300,470.00 | -100% | +9.8% | +41.1% |